Condition: Advanced Gastric Cancer · Sponsor: Yonsei University
* Treatment effectiveness in the real world * Adverse effects * Tissue samples collected (multiplex IHC to assess PD-L1 expression, MMR gene status, and Claudin18.2) * Blood samples collected (ctDNA, scRNAseq, or immune cell profiling)
This description comes directly from the study's public registry record.
Sun Young Rha · 82-2-2227-8406 · Rha7655@yuhs.ac
minkyu Jung · 82-2-2227-8406 · minkjung@yuhs.ac
Always discuss trial participation with your own doctor first.
| Severance Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06767449